Clinical Trials Directory

Trials / Conditions / ITP - Immune Thrombocytopenia

ITP - Immune Thrombocytopenia

16 registered clinical trials studyying ITP - Immune Thrombocytopenia — 11 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAvatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia
NCT07278908
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2 / Phase 3
RecruitingA Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thro
NCT07194850
argenxPhase 2 / Phase 3
Not Yet Recruiting"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Th
NCT07014904
Sohag University—
RecruitingOM336 in Autoimmune Cytopenias
NCT07083960
Ouro MedicinesPhase 1
RecruitingEltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
NCT07093606
Sohag UniversityN/A
RecruitingExploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) -
NCT07133659
Al-Mustansiriyah UniversityPhase 4
Not Yet RecruitingRipertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure
NCT06790888
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyN/A
RecruitingMesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia
NCT06813157
Guangzhou Bio-gene Technology Co., LtdN/A
RecruitingRESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
NCT06919341
Fundación Española de Hematología y Hemoterapía—
WithdrawnThe Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune
NCT06291415
HutchmedPhase 1
RecruitingEfficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)
NCT06352281
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaPhase 1 / Phase 2
UnknownImmune Markers in Pediatric ITP on Second Line Therapy
NCT06093529
Assiut University—
Not Yet RecruitingThrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
NCT06137105
Assiut University—
UnknownHigh-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Dia
NCT05943691
Shandong UniversityPhase 2
CompletedReal World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP
NCT05613296
Gruppo Italiano Malattie EMatologiche dell'Adulto—
UnknownExplore the Relationship Between Platelet Count and Bleeding Score in ITP
NCT06273956
Assiut University—